chrisvoncsefalvay/vaers-outcomes huggingface dataset:
on unspecified dates, unspecified patients received improperly stored GARDASIL 9; No adverse effects reported; This spontaneous report was received from a pharmacy tech referring to multiple unspecified patients of unknown age and gender. The patients' medical history, concurrent conditions and concomitant medications were not reported.  On unspecified dates, the patients were vaccinated with improperly stored hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) lot # R024271 and expiration date 08-MAY-2021 (dose, frequency and route were not provided) for prophylaxis. The administered doses of the vaccines were stored with the temperature of 31.29 degrees Fahrenheit for 10 minutes. There was a digital data logger involved, but there was no previous temperature excursion.
Fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K20A) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever). At the time of the report, PYREXIA (Fever) outcome was unknown.      mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   No relevant concomitant medications was reported. Treatment information was not provided. After first 2 doses patient experienced fever.   This case was linked to MOD-2021-373142, MOD-2021-373950 (Patient Link).
Pt recv vax on 10/23/98; on 10/24/ pt exp redness, swelling, warmth & pain of Rt arm; tx=Advil &ice.
Injection sight began to become sore around 6:30pm on 12/28, which kept me up all night with the soreness worsening. Throughout the night, I had severe chills, which is not normal for me.
Patient received Moderna Vaccine at Hospital health vaccine clinic on 1/8/21. Patient was then signed up for pharmacy clinic to receive Pfizer vaccine on 1/28/21. No symptoms noted. Precautionary reporting.
Starting 8 hours after vaccine, I had 16 hours of extreme flu conditions: Fever, Chills, Aching, Dizziness. My body felt like it weighed 400 pounds - I had trouble turning over in bed. Im 56 years old an I have never ever had a flu that felt that bad...
Pt was given 1st HPV, 1st Hep A, and 2nd MENACTRA this morning at 11:15 today. Pt came back to office at 1500 today with hives. Facial edema, fever, red eyes, and itching. Pt took 2 BENADRYL prior to arrival. Pt was placed in room and doctor advised and went in to see pt and continues to monitor.
I had to have a tooth pulled, the dentist did a scan before he pulled the tooth and said my congestion was due to the all the fluid in the cavities in my head. I had congestion, slight headache, sore throat. I went to the doctor and was given medication to help clear up the congestion in my head to help prevent it from going to my lungs.
Patient experienced dizziness and fatigue 5 minutes after vaccination. At time of reaction patient has a blood pressure of 159/91.. per patient she has no chronic health conditions and is on not prescribed or otc medications
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 72-year-old female patient (not pregnant) received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 30Aug2023 at 13:30 as dose 6 (booster), single (Lot number: GNO928) at the age of 71 years, in right arm for covid-19 immunisation; covid-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown), as dose 4 (booster), single (Batch/Lot number: unknown) and as dose 5 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (05Oct2023) negative, notes: On day 7 after completing Paxlovid I still had a stuffy nose and tested with an  at-home-test kit negative; (07Oct2023) positive, notes: On day 9 I tested again because I woke up with laryngitis and was positive with an at-home-test kit. Therapeutic measures were taken as a result of drug ineffective, covid-19.
Left hand swollen, red, painful. Patient applied warm compress, Tylenol & used Medrol Pack
now it is in my eye; Chronic cases of shingles, now it is in eyes; This case was reported by a consumer via interactive digital media and described the occurrence of ophthalmic herpes zoster in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   In December 2022, the patient received Shingles vaccine. In December 2022, 2 weeks after receiving Shingles vaccine, the patient experienced ophthalmic herpes zoster (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the ophthalmic herpes zoster and shingles were not recovered/not resolved.   It was unknown if the reporter considered the ophthalmic herpes zoster and shingles to be related to Shingles vaccine.     Additional Information: GSK receipt date: 15-Dec-2022 Reporter's comment: The case was received from the patient via interactive digital media. The patient just got his/her shingles vaccination about 2 weeks ago and less than 2 weeks after vaccination, the patient have had chronic cases of shingles and now it was in the patient's eye. The patient asked that how badly could it affect them. Additional supportive information: The follow-up could not be possible as no contact details were available.
her arm hurt a little bit; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 19-Apr-2021 and was forwarded to Moderna on 19-Apr-2021.    This spontaneous case was reported by a patient family member or friend and describes the occurrence of PAIN IN EXTREMITY (her arm hurt a little bit) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (her arm hurt a little bit). At the time of the report, PAIN IN EXTREMITY (her arm hurt a little bit) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided.  No treatment medications were provided.   This case was linked to MOD21-078429, MOD21-078492, MOD21-078496 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 19-Apr-2021: Follow-up information received on 19-may-2021 contains non-significant information. Reporter mailed "no one has CM initials here".; Sender's Comments:  MOD21-078429:Crosslinked MOD21-078492:Crosslinked MOD21-078496:Crosslinked
patient after receiving vaccine was waiting in observation monitoring area and started to faint, her eyes rolled a little and then was fine, she was breathing properly but her companion was stating she didnt feel good, that was a little out of air.  during time pt never loose conciounes nor fell down. after a while was fine
sick; coughing; strep-throat; This is a spontaneous report from a Pfizer sponsored program support. A contactable female consumer (patient) reported that a 38-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EW0185), via an unspecified route of administration (left shoulder) on 12May2021 (at the age of 38 years old) as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. She received first shot on 12May2021, and wasn't able to get the second dose, it was scheduled after two weeks, but doesn't have exact date, and now it has been 42 days, yesterday, from first dose. Her second shot has been delayed due to strep-throat on May2021. She told it's been 43 days today and asks if she can take the second dose with the given time frame. If the second dose was given later than 6 weeks (42 days), the vaccination series does not need to be repeated. She was going to get it after two weeks, but then she got sick, her and her daughter got sick. She had strep throat, and was on antibiotics, and needed to finish antibiotics, and wait a few days after that, so it put her at this many days. Agent stated reporter was asking if she can still get second dose. She was unsure of the antibiotics she took, stated they are free at Publix there. She stated it's not a Z-pack, it's whatever they give her when have strep throat. She stated she did not take anything else for treatment and confirms she did not have any fever. Strep throat was in May2021 and has resolved, she was done with antibiotics. She still coughing, but just a tiny bit, but that's why she decided maybe today would be a good day to go. She stated the cough started about two weeks or more ago, and reports she was almost 100% better. She stated no tests were done, the doctor just looked at her. She stated she just went to the doctor for her yearly check-up, and she was getting sick, and the doctor looked at her throat, and said, it looked like she had strep throat, and gave her antibiotics. The strep-throat resulted in physician office visit. Therapeutic measures were taken as a result of strep-throat with antibiotics. The outcome of strep-throat was recovered on an unspecified date in 2021, coughing was recovering, sick was unknown.  Follow-Up (22Jul2021): Follow-up attempts are completed. No further information is expected.
Pt had received adult Td, MMR and Hep B approx. 5' later pt became slightly dizzy, no reports of nausea or blurred vision and had pt lie down. BP 98/64, P 66, R 18. Had very little to eat this am at vaccines. After 5' pt feeling "much better." No further problems noted.
pt had swelling of both feet & lt ankle; redness over rt foot; pt refused to bear wt on legs per mom; pt seemed to be in pain; felt warm; devel red bumps on abd & upper thighs;
tightness & stiffness in chest, like constriction, chills, 99.3, loss of appetite, sore gums;rx w/Motrin cont throughout next 24hr better on 8FEB98;called MD 9FEB98;
more than 42 days have passed for second dose; fluttering heart; chest pain; heart palpitations; shortness of breath; feeling of tightness in the chest; doctor said that could be inflammation of some kind; This spontaneous case was reported by a consumer and describes the occurrence of CARDIAC FLUTTER (fluttering heart) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 03-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced CARDIAC FLUTTER (fluttering heart) (seriousness criterion medically significant), CHEST PAIN (chest pain), PALPITATIONS (heart palpitations), DYSPNOEA (shortness of breath), CHEST DISCOMFORT (feeling of tightness in the chest) and INFLAMMATION (doctor said that could be inflammation of some kind). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (more than 42 days have passed for second dose). At the time of the report, CARDIAC FLUTTER (fluttering heart), CHEST PAIN (chest pain), PALPITATIONS (heart palpitations), DYSPNOEA (shortness of breath), CHEST DISCOMFORT (feeling of tightness in the chest), INFLAMMATION (doctor said that could be inflammation of some kind) and PRODUCT DOSE OMISSION ISSUE (more than 42 days have passed for second dose) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Electrocardiogram: low qrs (abnormal) EKG said Low QRS.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment drug information provided.  No concomitant drug information provided.  Within 30 minutes of vaccination patient had chest pain, heart palpitations/fluttering heart, shortness of breath and a feeling of tightness in the chest. Patients vitals were Ok The symptoms went on for 2 weeks but subsided little by little. Patient was scared to get a 2nd shot.  Company Comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   Most recent FOLLOW-UP information incorporated above includes: On 09-Aug-2021: Follow up document received has AE contact information updated.; Sender's Comments: .Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
1 of 4 pts vaxed during the last yr (different lots) who exp large hives @ inj site; hives described as red mound; no abscessed; pt had hives 3" x 2" in size & was unable to lift arm for a period of time;
Ocular migraine on 12APR21 at 8pm symptoms passed quickly; symptoms included sensitivity to bright lights Ocular migraine experienced at 11AM on 13APR21 while driving. Lost peripheral eyesight in left eye and had sensitivity to bright lights. Migraine developed after ocular symptoms dissipated.  Ocular migraine experienced at 1250PM on 15APR21; symptoms included blurry vision and jagged pulsing shapes. Migraine proceeded afterwards and was the highest intensity one experienced out of series since they began. Experienced intense head pain, nauseous-ness, and balance issues. Ocular migraine experienced 17APR21 at 11AM; symptoms included jagged pulsing shape that moved towards the edge of vision field over a course of 20 minutes. Migraine proceeded afterwards and symptoms included head pain and nauseous-ness.
chills, severe shaking, high temp 104, lasting approx 1 1/2hr, body aches, sweating profusely by 3AM recovered;problem breathing, some coughing;
Headache, Myalgia, NauseaVomiting, SORE ARM Narrative:
4 days fever over 102, vomiting, day 2 unable to stand or walk, shortness of breath for 3 days to the point it was hard to talk. day 3, delayed skin reaction hive at injection site, along with hives on chest, back, thighs. both feet and both hands fully numb for 3 days. severe headache.
Raised burning area to left arm, tender nodes, complained of "heaviness" in arm, no fever. Last tetanus > 10 years ago, no reported allergies. Tx'd by primary care provider 5/27/03, prescribed Keflex and Atarax - Dx: allergic reaction/cellulitis.
Information has been received from a consumer referring to a 13 years old male patient. Information about concurrent condition, concomitant medication, drug reactions/allergies and pertinent medical history was not provided. On an unknown date, the patient was vaccinated with unspecified HPV vaccine for prophylaxis. The reporter did not clarify which HPV vaccine brand, valent or manufacturer had been administered but a Merck vaccine could not be ruled out (product origin unknown). The reporter reported that on an unknown date in August 2018 the patient died after receiving the HPV vaccine. It was unknown if an autopsy was performed or not.  The causality between the event and the HPV vaccine was not reported.
Localized reaction- bruise-like (blue) redness, swelling, "painful" as (described by patient) around the site of vaccine.
I developed discomfort in my right leg while sitting a few weeks after receiving the booster shot. I ignored the discomfort and would stand up and walk around. Over the course of the next couple months I continued to notice discomfort, only when sitting. On February 27th of 2022, I started to limp and felt a burning pain in my right calf. After a week of limping around I couldn't take the pain any more and on Saturday morning the 5th of March I went to urgent care where I was given an ultrasound after the doctor observed a substantial amount of edema in my right leg.  After the ultrasound the doctor told me I had a "large blood clot" in my leg and was diagnosed as having DVT.
Pt did not respond to series of Recombivax (2 doses) & Engerix-B (1 dose);  Recv Engerix-B booster dose & lab values showed titer borderline.
Information has been received from a pharmacist via field representative referring to a patient of unknown age and gender. Information about medical history and concurrent conditions were unspecified. On an unknown date the patient was vaccinated with ZOSTAVAX (lot number, dose and route were unknown). Concomitant medications were unspecified. On an unknown date, after vaccination, the patient developed cellulitis (unspecified location). The outcome of cellulitis was unknown. The causality between the event and ZOSTAVAX was unknown. Additional information has been requested.
Headache, Myalgia, Arthralgia, Fever, Diarrhea, NauseaVomiting, fatigue Narrative:
Approx 5 min after receiving vaccine, pt felt faint and nauseous, was pale and sweating. Helped pt to lie flat on floor with legs elavated, applied cool compress to forehead. Pt stated feeling better immediately. After a period of time, helped pt back to chair to wait with companion.
Approx. 2 min. after receiving injection was unable to breath, got very hot and flushed BP was 172/92 and O2 Sat. was 88%. Placed on O2 sats up to 99% and BP decreased 151/62-flush receded. Sent home for rest all day.
4x6 redness with he middle 2x3 swollen, 99.8 fever, watery eyes, difficulty breathing, using inhaler, raised rash warm to touch, itchy when Benadryl wears off.
Patient developed shingles a couple of days after administration of her vaccine. She has never had shingles before, and was in good health. She has no chronic conditions.
This case was reported by a consumer via interactive digital media and described the occurrence of drug dose administration interval too long in a patient who received Herpes zoster (shingrix) for prophylaxis. Previously administered products included shingrix (1st dose received on an unknown date). On an unknown date, the patient received the 2nd dose of shingrix. On an unknown date, unknown after receiving shingrix, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown. Additional details were reported as follows: The case was reported by the patient. The age at vaccination was not applicable for this report. The patient taking the 2nd shingrix vaccine more than 6 months after the 1st dose which led to lengthening of vaccination schedule. No contact details were reported.
vaccine clinic was sent out to parents to register 5 to 11 year old children. all signs at facility said location for 5 to 11 year old covid vaccine clinic.--child ended up being 15 years old
Information has been received from a physician referring to a patient of unknown age and gender. The patient's medical history or concurrent condition were not provided. In approximately July 2014, "about a year ago", the patient was vaccinated with a dose of GARDASIL (injection, lot#, dose, route were unspecified). No concomitant therapy was provided. On an unknown date after receiving the GARDASIL, the patient developed a "large swollen red area" at the injection site that was "warm to the touch". The physician stated that the patient recovered "within a week or two". The physician declined to provide any further information as he stated that this was already reported via the VAERS system. Additional information has been requested.
Lymphadenopathy supraclavicular nodes, left side; This is a spontaneous report from a contactable physician. A 40-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EL0140)  via an unspecified route of administration in left arm on 18Dec2020 12:30 at single dose for covid-19 immunization. The vaccine was administered in a hospital. Medical history included Known allergies with Penicillin. The patient was not pregnant. The patient was not diagnosed with COVID-19prior to vaccination. There were no concomitant medications. On 21Dec2020, the patient experienced Lymphadenopathy supraclavicular nodes, left side starting day 3 post vaccine and persistent to current with outcome of recovering. There was no treatment reported for the event. The event was assessed as non-serious. The patient was not tested for COVID-19 post vaccination.
Fever, chills, body aches, sore arm, pink bicep, warm to touch, grapefruit size area of redness, injection site sore.
I had a headache within 20 minutes of the vaccine. I had taken the methotrexate. I became floaty. I have not eaten since I had my vaccine. I have had headaches and fevers daily. The only thing that is happy with my stomach is water. My oxygen level is between 92 AND 98. If I cough hard, it feels like a lot of water gets released. When I went to an urgent care center, they did a COVID-19 and RSV test and both were negative. I am still having a fever between 101.7 and 101.4 which I am treating with TYLENOL every 4 hours. I had a fever today of 101.7. I have not been able to return to work due to this. If this continues thru tomorrow, I will have to go see another doctor.
Tx started on presentation to medical 2/3/03. Large are erythema from site on right arm extending below elbow and decreasing ROM of elbow. Measures > 120 mm. That involved Rx- Prednisone 20 mg PO 2 days x 5 - Hydroceftson (topical) 1% AAA TID - Ice to site. For 3rd Anthrax premedicated NOC at 40 mg prednisone. Received another 40 mg prednisone at time of vax, which was given IM. No adverse response to 3rd Anthrax.
Hot, red, sore, itching lump at injection site. Two weeks later and there is a bruise.
Red face; This spontaneous case was reported by a patient and describes the occurrence of ERYTHEMA (Red face) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018b21a) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Apr-2021, the patient experienced ERYTHEMA (Red face). At the time of the report, ERYTHEMA (Red face) outcome was unknown. Not Provided          No concomitant medication was reported.  Treatment information not provided.  Action taken with mRNA-1273 in response to the events was not applicable.
This spontaneous report as received from an other health professional refers to a patient of an unknown age. On 25-AUG-2017, the patient was vaccinated with ZOSTAVAX lot # M023687, subcutaneous for prophylaxis. Concomitant therapies included sterile diluent. On 25-AUG-2017, the patient experienced expired product administered. No adverse effects were reported. The outcome of expired product administered and no adverse event was unknown.